Press Releases
- Filter by
- Categories
- Tags
- Authors
- Show all
March 6, 2019
Published by Adelle McGourty at March 6, 2019
Categories
Dublin, Ireland, March 06 2019 – DS Biopharma (DS) today announced positive results from a new study where continued treatment with 5% DS107 cream not only […]
November 19, 2018
Published by Adelle McGourty at November 19, 2018
Categories
Dublin, Ireland, November 19th 2018 – DS Biopharma (DS), a privately held clinical stage biopharmaceutical company specialising in the development of novel bioactive lipids, today announced […]
October 18, 2018
Published by Adelle McGourty at October 18, 2018
Categories
Dublin, Ireland, October 18th 2018 – DS Biopharma (DS), a privately held biopharmaceutical company, today announced that oral treatment with DS107 reversed the molecular signature of […]
October 3, 2018
Published by Adelle McGourty at October 3, 2018
Categories
DS Biopharma announces positive top-line phase 2b trial results for DS107 as a topical treatment for mild to moderate atopic dermatitis Dublin, Ireland, October 3rd 2018 […]
December 11, 2017
Published by Adelle McGourty at December 11, 2017
Categories
Dublin, Ireland, December 11th, 2017 – DS Biopharma (DS), a clinical stage biopharmaceutical company, today announced receipt of allowance for a patent application in the United […]
May 8, 2017
Published by Adelle McGourty at May 8, 2017
Categories
Dublin, Ireland, May 8th, 2017 – DS Biopharma (DS), a clinical stage biopharmaceutical company, today announced the appointment of Professor Brendan Buckley as a non-executive director […]
April 13, 2017
Published by Adelle McGourty at April 13, 2017
Categories
Dublin, Ireland, April 13th, 2017 – DS Biopharma (DS), a clinical stage biopharmaceutical company, today announced receipt of allowance for a patent application in the United […]
February 7, 2017
Published by Adelle McGourty at February 7, 2017
Categories
Dublin, Ireland, February 7, 2017 – DS Biopharma (DS), a clinical stage biopharmaceutical company, today announced the appointment of Jane Hollingsworth as a non-executive director to […]
January 6, 2017
Published by micadmin at January 6, 2017
Categories
Dublin, Ireland, 6th January, 2017: DS Biopharma (DS), a privately held, clinical stage, pharmaceutical drug discovery and development company, today announced that recruitment has begun in […]
November 28, 2016
Published by Rachel Brennan at November 28, 2016
Categories
Dublin, Ireland, 28th November, 2016: DS Biopharma (DS), a privately held drug discovery and development company, today announced that it will present an overview of the […]
September 29, 2016
Published by Rachel Brennan at September 29, 2016
Categories
Dublin, Ireland, 29th September 2016: DS Biopharma (DS) will today present data on their Phase IIa study with DS107 for the treatment of atopic dermatitis at […]
September 15, 2016
Published by Mark O'Neill at September 15, 2016
Categories
Dublin, Ireland, 14th September 2016: DS Biopharma (DS) today announced the appointment of Dr. Markus Weissbach (MD, PhD) to Chief Operating Officer. Markus has been Medical […]
August 23, 2016
Published by Rachel Brennan at August 23, 2016
Categories
Dublin, Ireland, 22 August 2016: DS Biopharma (DS), a privately held drug discovery and development company with industry-leading expertise in lipid science, today announces the launch […]
January 7, 2016
Published by Rachel Brennan at January 7, 2016
Categories
Dublin, Ireland, January 7th, 2016 – DS Biopharma (DS), a privately held biopharmaceutical company, today announced positive top-line results from a Phase IIa clinical trial of […]
September 25, 2015
Published by Rachel Brennan at September 25, 2015
Categories
Dublin, Ireland, September 25, 2015 – DS Biopharma, a privately held biopharmaceutical company, today announced the appointment of Leopoldo Zambeletti as a Non-Executive Director to the […]